PMID- 36807912 OWN - NLM STAT- MEDLINE DCOM- 20230606 LR - 20230606 IS - 1097-0010 (Electronic) IS - 0022-5142 (Linking) VI - 103 IP - 9 DP - 2023 Jul TI - Digestion profile, antioxidant, and antidiabetic capacity of Morchella esculenta exopolysaccharide: in vitro, in vivo and microbiota analysis. PG - 4401-4412 LID - 10.1002/jsfa.12513 [doi] AB - BACKGROUND: Novel functional polysaccharides from fungi are important nutraceuticals. An exopolysaccharide, Morchella esculenta exopolysaccharide (MEP 2), was extracted and purified from the fermentation liquor of M. esculenta. The aim of this study was to investigate its digestion profile, antioxidant capacity, and effect on the microbiota composition in diabetic mice. RESULTS: The study found that MEP 2 was stable during in vitro saliva digestion but was partially degraded during gastric digestion. The digest enzymes exerted a negligible effect on the chemical structure of MEP 2. Molecular weight and atomic force microscope (AFM) images suggest that both smaller chains and larger aggregations were produced. Scanning electron microscope (SEM) images reveal that the surface morphology was much altered after intestinal digestion. After digestion, the antioxidant ability increased as revealed by the 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) assays. Both MEP 2 and its digested components showed strong alpha-amylase and moderate alpha-glucosidase inhibition activity, leading us to further investigate its ability to modulate the diabetic symptoms. The MEP 2 treatment ameliorated the inflammatory cell infiltration and increased the size of pancreas inlets. Serum concentration of HbA1c was significantly reduced. Blood glucose level during the oral glucose tolerance test (OGTT) was also slightly lower. The MEP 2 increased the diversity of the gut microbiota and modulated the abundance of several important bacteria including Alcaligenaceae, Caulobacteraceae, Prevotella, Brevundimonas, Demequina, and several Lachnospiraceae species. CONCLUSION: It was found that MEP 2 was partially degraded during in vitro digestion. Its potential antidiabetic bioactivity may be associated with its alpha-amylase inhibition and gut microbiome modulation ability. (c) 2023 Society of Chemical Industry. CI - (c) 2023 Society of Chemical Industry. FAU - Wu, Haishan AU - Wu H AD - School of Food and Biological Engineering, Hefei University of Technology, Hefei, P.R. China. FAU - Chen, Jing AU - Chen J AD - Teaching and Research Section of Clinical Nursing, Xiangya Hospital, Central South University, Changsha, China. AD - Department of Oral Mucosa, Center of Stomatology, Xiangya Hospital, Central South University, Changsha, China. FAU - Liu, Yuting AU - Liu Y AD - School of Food and Biological Engineering, Hefei University of Technology, Hefei, P.R. China. FAU - Cheng, Haoran AU - Cheng H AD - School of Food and Biological Engineering, Hefei University of Technology, Hefei, P.R. China. FAU - Nan, Jian AU - Nan J AD - School of Food and Biological Engineering, Hefei University of Technology, Hefei, P.R. China. FAU - Park, Hyun Jin AU - Park HJ AD - School of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea. FAU - Yang, Liu AU - Yang L AUID- ORCID: 0000-0001-5133-0470 AD - School of Food and Biological Engineering, Hefei University of Technology, Hefei, P.R. China. FAU - Li, Jinglei AU - Li J AUID- ORCID: 0000-0001-8814-8672 AD - School of Food and Biological Engineering, Hefei University of Technology, Hefei, P.R. China. LA - eng GR - 31700015/National Natural Science Foundation of China/ GR - 1808085QC66/Natural Science Foundation of Anhui Province/ PT - Journal Article DEP - 20230313 PL - England TA - J Sci Food Agric JT - Journal of the science of food and agriculture JID - 0376334 RN - 0 (Antioxidants) RN - 0 (Hypoglycemic Agents) RN - EC 3.2.1.1 (alpha-Amylases) RN - Morchella esculenta SB - IM MH - Animals MH - Mice MH - Antioxidants/pharmacology/chemistry MH - Hypoglycemic Agents/pharmacology MH - *Diabetes Mellitus, Experimental/drug therapy MH - *Microbiota MH - alpha-Amylases MH - Digestion OTO - NOTNLM OT - AFM OT - DSC OT - FTIR OT - diabetic mice OT - digestion profile EDAT- 2023/02/23 06:00 MHDA- 2023/06/06 06:42 CRDT- 2023/02/22 12:17 PHST- 2022/12/11 00:00 [revised] PHST- 2022/01/13 00:00 [received] PHST- 2023/02/19 00:00 [accepted] PHST- 2023/06/06 06:42 [medline] PHST- 2023/02/23 06:00 [pubmed] PHST- 2023/02/22 12:17 [entrez] AID - 10.1002/jsfa.12513 [doi] PST - ppublish SO - J Sci Food Agric. 2023 Jul;103(9):4401-4412. doi: 10.1002/jsfa.12513. Epub 2023 Mar 13.